Decitabine-cedazuridine in patients with MDS and <i>TP53</i> mutations

Samuel Urrutia, Koji Sasaki, Alex Bataller, Hagop Kantarjian, Guillermo Montalban-Bravo, James McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer Zeidan, Michael Savona, Aram Oganesian, Yuri Sano, Harold N. Keer, Guillermo Garcia-Manero

Open source

DOI: 10.1182/bloodadvances.2025017745
Published: 2026-02-02
Container: Blood Advances
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025017745,
  title = {Decitabine-cedazuridine in patients with MDS and
                    <i>TP53</i>
                    mutations},
  author = {Samuel Urrutia and Koji Sasaki and Alex Bataller and Hagop Kantarjian and Guillermo Montalban-Bravo and James McCloskey and Elizabeth A. Griffiths and Karen Yee and Amer Zeidan and Michael Savona and Aram Oganesian and Yuri Sano and Harold N. Keer and Guillermo Garcia-Manero},
  year = {2026},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025017745},
  url = {https://doi.org/10.1182/bloodadvances.2025017745}
}

RIS

TY  - JOUR
TI  - Decitabine-cedazuridine in patients with MDS and
                    <i>TP53</i>
                    mutations
AU  - Samuel Urrutia
AU  - Koji Sasaki
AU  - Alex Bataller
AU  - Hagop Kantarjian
AU  - Guillermo Montalban-Bravo
AU  - James McCloskey
AU  - Elizabeth A. Griffiths
AU  - Karen Yee
AU  - Amer Zeidan
AU  - Michael Savona
AU  - Aram Oganesian
AU  - Yuri Sano
AU  - Harold N. Keer
AU  - Guillermo Garcia-Manero
PY  - 2026
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025017745
UR  - https://doi.org/10.1182/bloodadvances.2025017745
ER  -

APA

Urrutia, S., Sasaki, K., Bataller, A., Kantarjian, H., Montalban-Bravo, G., McCloskey, J., Griffiths, E. A., Yee, K., Zeidan, A., Savona, M., Oganesian, A., Sano, Y., Keer, H. N., & Garcia-Manero, G. (2026). Decitabine-cedazuridine in patients with MDS and <i>TP53</i> mutations. Blood Advances. https://doi.org/10.1182/bloodadvances.2025017745

Source records

crossref · retrieved 2026-09-26T07:57:32.736Z